
Howard V. Owens Jr.
Examiner (ID: 6061)
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623 |
| Total Applications | 421 |
| Issued Applications | 221 |
| Pending Applications | 107 |
| Abandoned Applications | 92 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6569065
[patent_doc_number] => 20020165244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-07
[patent_title] => 'Mucin synthesis inhibitors'
[patent_app_type] => new
[patent_app_number] => 09/920287
[patent_app_country] => US
[patent_app_date] => 2001-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 11479
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20020165244.pdf
[firstpage_image] =>[orig_patent_app_number] => 09920287
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/920287 | Mucin synthesis inhibitors | Aug 1, 2001 | Abandoned |
Array
(
[id] => 6017631
[patent_doc_number] => 20020103350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-01
[patent_title] => 'Materials and methods for binding nucleic acids to surfaces'
[patent_app_type] => new
[patent_app_number] => 09/910697
[patent_app_country] => US
[patent_app_date] => 2001-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1670
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20020103350.pdf
[firstpage_image] =>[orig_patent_app_number] => 09910697
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/910697 | Materials and methods for binding nucleic acids to surfaces | Jul 19, 2001 | Issued |
Array
(
[id] => 6546496
[patent_doc_number] => 20020137780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-26
[patent_title] => 'Differentiating agents for the treatment of inflammatory intestinal diseases'
[patent_app_type] => new
[patent_app_number] => 09/896984
[patent_app_country] => US
[patent_app_date] => 2001-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5130
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20020137780.pdf
[firstpage_image] =>[orig_patent_app_number] => 09896984
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/896984 | Differentiating agents for the treatment of inflammatory intestinal diseases | Jul 1, 2001 | Abandoned |
Array
(
[id] => 1034541
[patent_doc_number] => 06875751
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-04-05
[patent_title] => '3′-prodrugs of 2′-deoxy-β-L-nucleosides'
[patent_app_type] => utility
[patent_app_number] => 09/883033
[patent_app_country] => US
[patent_app_date] => 2001-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 24
[patent_no_of_words] => 41373
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/875/06875751.pdf
[firstpage_image] =>[orig_patent_app_number] => 09883033
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/883033 | 3′-prodrugs of 2′-deoxy-β-L-nucleosides | Jun 14, 2001 | Issued |
Array
(
[id] => 5802550
[patent_doc_number] => 20020010322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-24
[patent_title] => 'New aromatic derivatives substituted by a ribose, their preparation process and their use as medicaments'
[patent_app_type] => new
[patent_app_number] => 09/875860
[patent_app_country] => US
[patent_app_date] => 2001-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18416
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20020010322.pdf
[firstpage_image] =>[orig_patent_app_number] => 09875860
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/875860 | Aromatic derivatives substituted by a ribose, their preparation process and their use as medicaments | Jun 6, 2001 | Issued |
Array
(
[id] => 6756353
[patent_doc_number] => 20030004130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-02
[patent_title] => 'Homogeneous pharmaceutical compositions containing zidovudine and lamivudine'
[patent_app_type] => new
[patent_app_number] => 09/863930
[patent_app_country] => US
[patent_app_date] => 2001-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5946
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20030004130.pdf
[firstpage_image] =>[orig_patent_app_number] => 09863930
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/863930 | Homogeneous pharmaceutical compositions containing zidovudine and lamivudine | May 23, 2001 | Abandoned |
Array
(
[id] => 996614
[patent_doc_number] => 06914054
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-07-05
[patent_title] => 'Methods and compositions for treating hepatitis C virus'
[patent_app_type] => utility
[patent_app_number] => 09/864078
[patent_app_country] => US
[patent_app_date] => 2001-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 48866
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/914/06914054.pdf
[firstpage_image] =>[orig_patent_app_number] => 09864078
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/864078 | Methods and compositions for treating hepatitis C virus | May 22, 2001 | Issued |
Array
(
[id] => 1182083
[patent_doc_number] => 06737518
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-05-18
[patent_title] => 'Process for preparation of 4,5-epoxymorphinan-6-oxyglucuronides'
[patent_app_type] => B1
[patent_app_number] => 09/700035
[patent_app_country] => US
[patent_app_date] => 2001-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2691
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/737/06737518.pdf
[firstpage_image] =>[orig_patent_app_number] => 09700035
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/700035 | Process for preparation of 4,5-epoxymorphinan-6-oxyglucuronides | May 17, 2001 | Issued |
Array
(
[id] => 6082466
[patent_doc_number] => 20020082242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-27
[patent_title] => 'Compositions and methods of double-targeting virus infections and cancer cells'
[patent_app_type] => new
[patent_app_number] => 09/844201
[patent_app_country] => US
[patent_app_date] => 2001-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18648
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20020082242.pdf
[firstpage_image] =>[orig_patent_app_number] => 09844201
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/844201 | Compositions and methods of double-targeting virus infections and cancer cells | Apr 26, 2001 | Issued |
Array
(
[id] => 6064134
[patent_doc_number] => 20020032169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-14
[patent_title] => 'Aminosugar, glycosaminoglycan, and S-adenosylmethionine composition for the treatment and repair of connective tissue'
[patent_app_type] => new
[patent_app_number] => 09/834726
[patent_app_country] => US
[patent_app_date] => 2001-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7561
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20020032169.pdf
[firstpage_image] =>[orig_patent_app_number] => 09834726
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/834726 | Aminosugar, glycosaminoglycan, and S-adenosylmethionine composition for the treatment and repair of connective tissue | Apr 15, 2001 | Issued |
Array
(
[id] => 1271692
[patent_doc_number] => 06653455
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-25
[patent_title] => 'Crystallization of doxorubicin hydrochloride'
[patent_app_type] => B1
[patent_app_number] => 09/807451
[patent_app_country] => US
[patent_app_date] => 2001-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4955
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/653/06653455.pdf
[firstpage_image] =>[orig_patent_app_number] => 09807451
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/807451 | Crystallization of doxorubicin hydrochloride | Apr 12, 2001 | Issued |
Array
(
[id] => 6545354
[patent_doc_number] => 20020137725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-26
[patent_title] => 'Use of tagatose in promoting cardiovascular health'
[patent_app_type] => new
[patent_app_number] => 09/811654
[patent_app_country] => US
[patent_app_date] => 2001-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 438
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20020137725.pdf
[firstpage_image] =>[orig_patent_app_number] => 09811654
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/811654 | Use of tagatose in promoting cardiovascular health | Mar 19, 2001 | Abandoned |
Array
(
[id] => 6908312
[patent_doc_number] => 20010011079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-02
[patent_title] => 'Method for large-scale production of di(uridine 5\')-tetraphosphate and salts thereof'
[patent_app_type] => new
[patent_app_number] => 09/805332
[patent_app_country] => US
[patent_app_date] => 2001-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6098
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0011/20010011079.pdf
[firstpage_image] =>[orig_patent_app_number] => 09805332
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/805332 | Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof | Mar 11, 2001 | Issued |
Array
(
[id] => 750830
[patent_doc_number] => 07022833
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-04-04
[patent_title] => 'Process for the preparation of phosphorothioate triesters'
[patent_app_type] => utility
[patent_app_number] => 10/220353
[patent_app_country] => US
[patent_app_date] => 2001-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6310
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/022/07022833.pdf
[firstpage_image] =>[orig_patent_app_number] => 10220353
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/220353 | Process for the preparation of phosphorothioate triesters | Feb 22, 2001 | Issued |
| 09/720391 | 2-(PURIN-9-YL)-TETRAHYDEOFURAN-3,4- DIOL DERIVATIVES | Feb 22, 2001 | Abandoned |
Array
(
[id] => 5789594
[patent_doc_number] => 20020161219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-31
[patent_title] => 'Non-enzymatic large scale synthesis of RNA'
[patent_app_type] => new
[patent_app_number] => 09/790440
[patent_app_country] => US
[patent_app_date] => 2001-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13187
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20020161219.pdf
[firstpage_image] =>[orig_patent_app_number] => 09790440
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/790440 | Non-enzymatic large scale synthesis of RNA | Feb 20, 2001 | Abandoned |
Array
(
[id] => 7079018
[patent_doc_number] => 20010041685
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-15
[patent_title] => 'Mucin synthesis inhibitors'
[patent_app_type] => new
[patent_app_number] => 09/774243
[patent_app_country] => US
[patent_app_date] => 2001-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 10858
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20010041685.pdf
[firstpage_image] =>[orig_patent_app_number] => 09774243
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/774243 | Mucin synthesis inhibitors | Jan 30, 2001 | Issued |
Array
(
[id] => 7094037
[patent_doc_number] => 20010034435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-25
[patent_title] => 'Process and equipment for plasmid purification'
[patent_app_type] => new
[patent_app_number] => 09/774284
[patent_app_country] => US
[patent_app_date] => 2001-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8550
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20010034435.pdf
[firstpage_image] =>[orig_patent_app_number] => 09774284
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/774284 | Process and equipment for plasmid purification | Jan 28, 2001 | Issued |
Array
(
[id] => 1229848
[patent_doc_number] => RE038426
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2004-02-10
[patent_title] => '5-O-deosaminyl 6-O-methyl erythronolide A derivatives, preparation method therefor and use thereof for preparing biologically active materials'
[patent_app_type] => E1
[patent_app_number] => 09/772277
[patent_app_country] => US
[patent_app_date] => 2001-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2085
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/038/RE038426.pdf
[firstpage_image] =>[orig_patent_app_number] => 09772277
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/772277 | 5-O-deosaminyl 6-O-methyl erythronolide A derivatives, preparation method therefor and use thereof for preparing biologically active materials | Jan 28, 2001 | Issued |
Array
(
[id] => 7001193
[patent_doc_number] => 20010053855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-12-20
[patent_title] => 'Oligonucleotide protecting groups'
[patent_app_type] => new
[patent_app_number] => 09/745642
[patent_app_country] => US
[patent_app_date] => 2000-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4995
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20010053855.pdf
[firstpage_image] =>[orig_patent_app_number] => 09745642
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/745642 | Oligonucleotide protecting groups | Dec 21, 2000 | Issued |